Teva, Alvotech secure US license date for AVT04, a proposed biosimilar to Stelara Ruchika Sharma13 Jun 2023 1:30 PM ISTIceland: Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...
Janssen seeks USFDA nod for Carvykti for relapsed or refractory multiple myeloma Ruchika Sharma8 Jun 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License...
Janssen seeks USFDA nod for single tablet combination therapy of Macitentan, Tadalafil for Pulmonary Arterial Hypertension Ruchika Sharma31 May 2023 3:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a New Drug Application (NDA) to the U.S. Food...
Janssen Milvexian gets USFDA fast track designation for Ischemic Stroke, Acute Coronary Syndrome, Atrial Fibrillation Ruchika Sharma26 May 2023 3:15 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that all three prospective indications for milvexian, an ...
Amgen settles patent lawsuit over biosimilar of JnJ's Stelara Ruchika Sharma25 May 2023 2:50 PM ISTStelara is a biologic drug, meaning it is derived from living cells and cannot be exactly duplicated.
J&J agrees to retain all talc related liabilities from litigation in US, Canada Ruchika Sharma30 April 2023 2:30 PM ISTUnited States: Johnson & Johnson said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United...
JnJ seeks valuation of up to USD 43 billion in IPO of consumer health unit Kenvue Ruchika Sharma25 April 2023 2:46 PM ISTNew Jersey: Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its...
Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations Ruchika Sharma22 April 2023 11:32 AM ISTThe EC authorisation, which also marks the first worldwide approval for AKEEGA, is based on results of the randomised, double-blind, placebo...
JnJ talc unit faces skepticism on bankruptcy settlement support Ruchika Sharma12 April 2023 2:43 PM ISTUS: A Johnson & Johnson company on Tuesday defended its second attempt to resolve talc lawsuits in bankruptcy, telling a U.S. judge it can...
Johnson and Johnson talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say Ruchika Sharma11 April 2023 2:48 PM ISTUS: Johnson & Johnson’s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny...
Johnson & Johnson proposes USD 8.9 billion settlement for talc cancer claims Roshni Dhar6 April 2023 3:53 PM ISTUS pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum...
Health Bulletin 5/April/2023 Roshni Dhar5 April 2023 5:34 PM ISTHere are the top health stories for the day:People need to remain vigilant against new COVID strain: OfficialRajasthan doctors call off strike on RTH...
